InvestorsHub Logo

dmiller

09/13/20 7:11 PM

#298792 RE: lizzy241 #298772

Amarin is a one drug co with no pipeline and lost its exclusivity in the US. Doesn't seem like anyone is interested even at $4. BO only exists in the mind of shareholders for the last 2-5 years.

north40000

09/13/20 8:58 PM

#298804 RE: lizzy241 #298772

Today’s PR from GILD confirms the WSJ news yesterday, see post # 298668. GILD may find Vascepa’s anti-inflammatory properties useful in combatting cytokines released by mabs in treating a host of solid tumors. Trodelvy has been approved by FDA, was launched in May 2020, and joins Yescarta and Tecartus as “Foundational to Gilead’s Oncolgy Franchise.”